Darovasertib
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-101569-50 mg |
| CAS # | 1874276-76-2 |
| Pricing | 50 mg, USD $610.0 |
| Synonyms | LXS196; IDE196 |
| MWt | 472.47 |
| Formula | C₂₂H₂₃F₃N₈O |
| Biological Activity | Darovasertib (LXS196) is a potent, selective and orally active protein kinase C (PKC) inhibitor, with IC50 values of 1.9 nM, 0.4 nM and 3.1 μM for PKCα, PKCθ and GSK3β, respectively. Darovasertib has the potential for uveal melanoma research[1][2]. |
| Purity | 99.68% |